February 7, 2019 Clinical Research/Diagn. M&A, Partnerships

Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of the agreement, Fluidigm and Indica Labs will cooperatively promote the next-generation digital pathology image analysis and image management platforms HALO®, HALO AI™and HALO Link™ in conjunction with... Read more

February 6, 2019 Clinical Research/Diagn.

Roche joins the World Federation of Hemophilia Humanitarian Aid Program

Basel, 06 February 2019 Roche joins the World Federation of Hemophilia Humanitarian Aid Program Hemlibra donation will provide prophylactic treatment to as many as 1,000 people with haemophilia A over five years in countries where there is little or no access to haemophilia treatment Donation will substantially increase the number of people receiving prophylactic treatment... Read more

February 5, 2019 Clinical Research/Diagn. M&A, Partnerships

FALCO biosystems and Promega Corporation MSI-IVD Kit Collaboration Obtains Approved Companion Diagnostic Status in Japan

Madison, WI USA. (February 5, 2019) Promega Corporation today announced FALCO biosystems of Kyoto, Japan, a core business company of FALCO HOLDINGS, working in collaboration with Promega microsatellite instability (MSI) chemistry and assay design, obtained companion diagnostic approval for FALCO’s MSI-IVD from Japan’s regulatory agency, the Ministry of Health, Labour and Welfare (MHLW). The MSI-IVD Kit (FALCO),... Read more

February 4, 2019 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

FEBRUARY 26, 2019 MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and Ning Zhou, CEO of Lisen, attended the meeting and signing ceremony. Bio-Techne is a leading provider of high-quality... Read more

February 4, 2019 Clinical Research/Diagn. Lab Top-10 PR/Corporate

MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease

Burlington, Massachusetts, February 4, 2019 — MilliporeSigma today announced the winners of its Advance Biotech Grantprogram in Europe. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their therapies to market. Applicants from emerging biotech companies across Europe were asked to describe their projects, the medical needs they solve,... Read more

February 4, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

GE Healthcare and Aga Khan University Hospital Pakistan announce strategic partnership

Dubai, UAE; January 29, 2019: On the sidelines of Arab Health 2019, the region’s leading healthcare exhibition, GE Healthcare and The Aga Khan University Hospital (AKUH) in Karachi, Pakistan, today announced a strategic partnership to give Pakistan’s leading private quaternary care hospital access to a new range of advanced medical imaging and diagnostic equipment. GE... Read more

January 30, 2019 Bio/Pharma/CRO Clinical Research/Diagn.

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue

Basel, 30 January 2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue The Alzheimer’s Prevention Initiative (API) study of crenezumab in familial Alzheimer’s disease continues Roche remains committed to ongoing clinical studies in Alzheimer’s disease, including GRADUATE Phase... Read more

January 28, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Microscopy

Thermo Fisher Scientific Signs Agreement to Sell its Anatomical Pathology Business

WALTHAM, Mass., Jan. 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation, a global innovator in healthcare solutions, for approximately $1.14 billion in cash. The Anatomical Pathology business is a... Read more

January 24, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships Product Launch

1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more

January 24, 2019 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools Product Launch

BIO-TECHNE LAUNCHES CELL AND GENE THERAPY PORTFOLIO

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more